Why the world needs $8 billion now to get us to COVID-Zero
Only when we have tools to detect, treat and prevent coronavirus disease everywhere, will we be able to stop the pandemic. Developing these tools requires new global partnerships and cooperation.
Developing a vaccine for COVID-19: what can we learn from past outbreaks?
Vaccines are one of our most powerful health tools. Here’s some of the lessons we’ve learned about the development and use of vaccines from past outbreaks.
How can we develop a COVID-19 vaccine quickly?
A COVID-19 vaccine would be an incredibly powerful tool to slow down the coronavirus pandemic. How do we develop one in record time?
COVID-Zero: how businesses can play a critical role in bringing the coronavirus pandemic to an end
By fully funding research and development for COVID-19 testing, treatment and vaccines we can reach COVID-Zero – no preventable deaths, no further lockdowns, no more disruption.
Greater investment is needed to help countries with the weakest health systems prepare for COVID-19
We’ve awarded £12 million, in partnership with DFID, to speed up global COVID-19 research and development and help low- and middle-income countries prepare. But more investment is needed.
Wellcome Trust building to become respite centre for local NHS staff
We're making our headquarters on Euston Road available as an official respite centre for local NHS staff responding to the coronavirus pandemic.
Wellcome joins the UK government, industry and universities in a step-change to COVID-19 testing
Wellcome is supporting a step-change in COVID-19 testing by the UK government. Partners include the NHS, Public Health England, diagnostics companies Thermo Fisher Scientific, QIAGEN and Randox, UK universities, Boots, Royal Mail and Amazon.
Can chloroquine prevent coronavirus disease? Only research will give us the answer
The COVID-19 Therapeutics Accelerator is funding clinical trials that will answer whether the anti-malarial drugs hydroxychloroquine and chloroquine can be used to prevent the spread of COVID-19.
A new way of developing vaccines for COVID-19 could help the world to prepare for future outbreaks
A vaccine for COVID-19 which uses cutting-edge RNA technology has entered phase 1 clinical trials. If successful, it could revolutionise the future of vaccine development.
Urgent investment needed for diagnostics, treatments and vaccines to end the COVID-19 pandemic
Now is not the time to make cautious investments: now is the time for courageous action to tackle COVID-19.